NextRNA Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- NextRNA Therapeutics's estimated annual revenue is currently $3.6M per year.
- NextRNA Therapeutics's estimated revenue per employee is $77,500
Employee Data
- NextRNA Therapeutics has 46 Employees.
- NextRNA Therapeutics grew their employee count by -12% last year.
NextRNA Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Business Officer & Chief Financial Officer | Reveal Email/Phone |
4 | VP, Head Drug Discovery | Reveal Email/Phone |
5 | Head Platform Technology | Reveal Email/Phone |
6 | VP, Head Computational Biology | Reveal Email/Phone |
7 | VP, Head Biology | Reveal Email/Phone |
8 | VP, Head Computational Biology | Reveal Email/Phone |
9 | Sr. Director, RNA and Protein Sciences | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
NextRNA Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is NextRNA Therapeutics?
NextRNA Therapeutics, Inc. is a MA-based newly founded biotechnology company committed to leading the next revolution of RNA-directed therapeutics. Based on the foundational work of Carl Novina at Dana-Farber Cancer Institute, NextRNA has established a proprietary target and drug discovery engine that enables us to systematically identify disease-relevant long non-coding RNAs and their interacting proteins, and develop selective small molecules to drug RNA-protein interactions. The company is currently advancing two small molecule therapeutic programs in oncology and immunology. NextRNA has assembled a highly experienced and competent team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$3.6M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 46 | -12% | N/A |
#2 | $6.6M | 46 | -8% | N/A |
#3 | $3.8M | 46 | N/A | N/A |
#4 | $5.3M | 46 | N/A | N/A |
#5 | $9.9M | 46 | 28% | N/A |